Cargando…
Clinical value of early detection of circulating tumour DNA-BRAF(V600mut) in patients with metastatic melanoma treated with a BRAF inhibitor
| Autores principales: | , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
ESMO Open
2017
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5519801/ https://www.ncbi.nlm.nih.gov/pubmed/28761746 http://dx.doi.org/10.1136/esmoopen-2017-000173 |
| _version_ | 1783251697683922944 |
|---|---|
| author | Louveau, Baptiste Tost, Jörg Mauger, Florence Sadoux, Aurélie Podgorniak, Marie-Pierre How-Kit, Alexandre Pages, Cécile Roux, Jennifer Da Meda, Laetitia Lebbe, Céleste Mourah, Samia |
| author_facet | Louveau, Baptiste Tost, Jörg Mauger, Florence Sadoux, Aurélie Podgorniak, Marie-Pierre How-Kit, Alexandre Pages, Cécile Roux, Jennifer Da Meda, Laetitia Lebbe, Céleste Mourah, Samia |
| author_sort | Louveau, Baptiste |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-5519801 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2017 |
| publisher | ESMO Open |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-55198012017-07-31 Clinical value of early detection of circulating tumour DNA-BRAF(V600mut) in patients with metastatic melanoma treated with a BRAF inhibitor Louveau, Baptiste Tost, Jörg Mauger, Florence Sadoux, Aurélie Podgorniak, Marie-Pierre How-Kit, Alexandre Pages, Cécile Roux, Jennifer Da Meda, Laetitia Lebbe, Céleste Mourah, Samia ESMO Open Correspondence ESMO Open 2017-06-21 /pmc/articles/PMC5519801/ /pubmed/28761746 http://dx.doi.org/10.1136/esmoopen-2017-000173 Text en © European Society for Medical Oncology (unless otherwise stated in the text of the article) 2017. All rights reserved. No commercial use is permitted unless otherwise expressly granted. This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
| spellingShingle | Correspondence Louveau, Baptiste Tost, Jörg Mauger, Florence Sadoux, Aurélie Podgorniak, Marie-Pierre How-Kit, Alexandre Pages, Cécile Roux, Jennifer Da Meda, Laetitia Lebbe, Céleste Mourah, Samia Clinical value of early detection of circulating tumour DNA-BRAF(V600mut) in patients with metastatic melanoma treated with a BRAF inhibitor |
| title | Clinical value of early detection of circulating tumour DNA-BRAF(V600mut) in patients with metastatic melanoma treated with a BRAF inhibitor |
| title_full | Clinical value of early detection of circulating tumour DNA-BRAF(V600mut) in patients with metastatic melanoma treated with a BRAF inhibitor |
| title_fullStr | Clinical value of early detection of circulating tumour DNA-BRAF(V600mut) in patients with metastatic melanoma treated with a BRAF inhibitor |
| title_full_unstemmed | Clinical value of early detection of circulating tumour DNA-BRAF(V600mut) in patients with metastatic melanoma treated with a BRAF inhibitor |
| title_short | Clinical value of early detection of circulating tumour DNA-BRAF(V600mut) in patients with metastatic melanoma treated with a BRAF inhibitor |
| title_sort | clinical value of early detection of circulating tumour dna-braf(v600mut) in patients with metastatic melanoma treated with a braf inhibitor |
| topic | Correspondence |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5519801/ https://www.ncbi.nlm.nih.gov/pubmed/28761746 http://dx.doi.org/10.1136/esmoopen-2017-000173 |
| work_keys_str_mv | AT louveaubaptiste clinicalvalueofearlydetectionofcirculatingtumourdnabrafv600mutinpatientswithmetastaticmelanomatreatedwithabrafinhibitor AT tostjorg clinicalvalueofearlydetectionofcirculatingtumourdnabrafv600mutinpatientswithmetastaticmelanomatreatedwithabrafinhibitor AT maugerflorence clinicalvalueofearlydetectionofcirculatingtumourdnabrafv600mutinpatientswithmetastaticmelanomatreatedwithabrafinhibitor AT sadouxaurelie clinicalvalueofearlydetectionofcirculatingtumourdnabrafv600mutinpatientswithmetastaticmelanomatreatedwithabrafinhibitor AT podgorniakmariepierre clinicalvalueofearlydetectionofcirculatingtumourdnabrafv600mutinpatientswithmetastaticmelanomatreatedwithabrafinhibitor AT howkitalexandre clinicalvalueofearlydetectionofcirculatingtumourdnabrafv600mutinpatientswithmetastaticmelanomatreatedwithabrafinhibitor AT pagescecile clinicalvalueofearlydetectionofcirculatingtumourdnabrafv600mutinpatientswithmetastaticmelanomatreatedwithabrafinhibitor AT rouxjennifer clinicalvalueofearlydetectionofcirculatingtumourdnabrafv600mutinpatientswithmetastaticmelanomatreatedwithabrafinhibitor AT damedalaetitia clinicalvalueofearlydetectionofcirculatingtumourdnabrafv600mutinpatientswithmetastaticmelanomatreatedwithabrafinhibitor AT lebbeceleste clinicalvalueofearlydetectionofcirculatingtumourdnabrafv600mutinpatientswithmetastaticmelanomatreatedwithabrafinhibitor AT mourahsamia clinicalvalueofearlydetectionofcirculatingtumourdnabrafv600mutinpatientswithmetastaticmelanomatreatedwithabrafinhibitor |